AR039221A1 - Combinaciones de epinastina, belladona y pseudoefedrina como formulaciones farmaceuticas - Google Patents
Combinaciones de epinastina, belladona y pseudoefedrina como formulaciones farmaceuticasInfo
- Publication number
- AR039221A1 AR039221A1 ARP030101144A ARP030101144A AR039221A1 AR 039221 A1 AR039221 A1 AR 039221A1 AR P030101144 A ARP030101144 A AR P030101144A AR P030101144 A ARP030101144 A AR P030101144A AR 039221 A1 AR039221 A1 AR 039221A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutically acceptable
- epinastine
- amount
- acceptable salt
- belladonna
- Prior art date
Links
- WHWZLSFABNNENI-UHFFFAOYSA-N epinastine Chemical compound C1C2=CC=CC=C2C2CN=C(N)N2C2=CC=CC=C21 WHWZLSFABNNENI-UHFFFAOYSA-N 0.000 title abstract 4
- 229960003449 epinastine Drugs 0.000 title abstract 4
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 6
- 239000000203 mixture Substances 0.000 abstract 4
- 241001106067 Atropa Species 0.000 abstract 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 2
- 230000001387 anti-histamine Effects 0.000 abstract 2
- 239000000739 antihistaminic agent Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 abstract 2
- 239000000850 decongestant Substances 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 2
- 229960003908 pseudoephedrine Drugs 0.000 abstract 2
- FMCGSUUBYTWNDP-ONGXEEELSA-N (1R,2S)-2-(dimethylamino)-1-phenyl-1-propanol Chemical compound CN(C)[C@@H](C)[C@H](O)C1=CC=CC=C1 FMCGSUUBYTWNDP-ONGXEEELSA-N 0.000 abstract 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 abstract 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 abstract 1
- FMCGSUUBYTWNDP-UHFFFAOYSA-N N-Methylephedrine Natural products CN(C)C(C)C(O)C1=CC=CC=C1 FMCGSUUBYTWNDP-UHFFFAOYSA-N 0.000 abstract 1
- 208000036284 Rhinitis seasonal Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229930013930 alkaloid Natural products 0.000 abstract 1
- 208000002205 allergic conjunctivitis Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 230000001078 anti-cholinergic effect Effects 0.000 abstract 1
- 208000024998 atopic conjunctivitis Diseases 0.000 abstract 1
- 229940092732 belladonna alkaloid Drugs 0.000 abstract 1
- GERIGMSHTUAXSI-UHFFFAOYSA-N bis(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 4-phenyl-2,3-dihydro-1h-naphthalene-1,4-dicarboxylate Chemical compound CN1C(C2)CCC1CC2OC(=O)C(C1=CC=CC=C11)CCC1(C(=O)OC1CC2CCC(N2C)C1)C1=CC=CC=C1 GERIGMSHTUAXSI-UHFFFAOYSA-N 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 abstract 1
- 229960002221 methylephedrine Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 208000017022 seasonal allergic rhinitis Diseases 0.000 abstract 1
- 230000001932 seasonal effect Effects 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02007568A EP1350512A1 (en) | 2002-04-03 | 2002-04-03 | Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR039221A1 true AR039221A1 (es) | 2005-02-09 |
Family
ID=27838061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030101144A AR039221A1 (es) | 2002-04-03 | 2003-04-02 | Combinaciones de epinastina, belladona y pseudoefedrina como formulaciones farmaceuticas |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030228359A1 (enExample) |
| EP (2) | EP1350512A1 (enExample) |
| JP (1) | JP2005522467A (enExample) |
| AR (1) | AR039221A1 (enExample) |
| AU (1) | AU2003221532A1 (enExample) |
| BR (1) | BR0308982A (enExample) |
| CA (1) | CA2477751A1 (enExample) |
| MX (1) | MXPA04009582A (enExample) |
| PE (1) | PE20040080A1 (enExample) |
| PL (1) | PL371382A1 (enExample) |
| RU (1) | RU2004132205A (enExample) |
| WO (1) | WO2003082285A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19954516A1 (de) * | 1999-11-12 | 2001-05-17 | Boehringer Ingelheim Int | Epinastin-haltige Lösungen |
| US20030104017A1 (en) * | 2001-10-26 | 2003-06-05 | Boehringer Ingelheim International Gmbh | Epinastine formulation for oral administration |
| CN1738610A (zh) * | 2003-01-22 | 2006-02-22 | 日绊株式会社 | 眼疾治疗用经皮吸收型制剂、其使用及眼疾治疗药向眼局部组织的转移方法 |
| WO2005030132A2 (en) * | 2003-09-24 | 2005-04-07 | Combinatorx, Incorporated | Therapeutic regimens for administering drug combinations |
| JP2007520509A (ja) * | 2004-02-06 | 2007-07-26 | メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト | 抗コリン薬による、又は抗ヒスタミン薬、ホスホジエステラーゼ４、又はコルチコステロイドとの組み合わせによる鼻炎治療薬 |
| JP4936420B2 (ja) * | 2005-08-02 | 2012-05-23 | 塩野義製薬株式会社 | 徐放性顆粒剤 |
| JP5162141B2 (ja) * | 2007-02-20 | 2013-03-13 | エスエス製薬株式会社 | フィルムコーティング用組成物 |
| RU2366446C1 (ru) * | 2008-06-27 | 2009-09-10 | Сергей Анатольевич Небера | Гомеопатическое средство для лечения конъюнктивитов |
| WO2010030418A1 (en) * | 2008-09-10 | 2010-03-18 | Micro-Dose Life Sciences Llc | Anti-fever botanical composition and uses thereof |
| KR101752014B1 (ko) * | 2009-05-01 | 2017-06-28 | 아데어 파마슈티컬스 인코포레이티드 | 고용량 및 저용량 약물들의 조합을 포함하는 구강붕해정 조성물 |
| JP5852816B2 (ja) * | 2010-09-10 | 2016-02-03 | ロート製薬株式会社 | 液状医薬組成物、及びこれを含有する軟カプセル剤 |
| RU2478377C1 (ru) * | 2011-08-08 | 2013-04-10 | Алексей Владимирович Брынцалов | Комбинированный препарат орвиум для устранения симптомов простудных заболеваний и гриппа |
| CN110237079B (zh) * | 2019-07-01 | 2021-05-14 | 山西大学 | 一种百部生物碱类似物的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10298107A (ja) * | 1997-04-25 | 1998-11-10 | Taisho Pharmaceut Co Ltd | 医薬組成物 |
| US6613357B2 (en) * | 2000-01-13 | 2003-09-02 | Osmotica Corp. | Osmotic device containing pseudoephedrine and an H1 antagonist |
-
2002
- 2002-04-03 EP EP02007568A patent/EP1350512A1/en not_active Withdrawn
-
2003
- 2003-03-25 US US10/396,234 patent/US20030228359A1/en not_active Abandoned
- 2003-03-28 AU AU2003221532A patent/AU2003221532A1/en not_active Abandoned
- 2003-03-28 RU RU2004132205/15A patent/RU2004132205A/ru not_active Application Discontinuation
- 2003-03-28 JP JP2003579822A patent/JP2005522467A/ja active Pending
- 2003-03-28 MX MXPA04009582A patent/MXPA04009582A/es unknown
- 2003-03-28 PL PL03371382A patent/PL371382A1/xx unknown
- 2003-03-28 CA CA002477751A patent/CA2477751A1/en not_active Abandoned
- 2003-03-28 WO PCT/EP2003/003263 patent/WO2003082285A1/en not_active Ceased
- 2003-03-28 BR BR0308982-7A patent/BR0308982A/pt not_active Application Discontinuation
- 2003-03-28 EP EP03717248A patent/EP1492532A1/en not_active Withdrawn
- 2003-04-01 PE PE2003000332A patent/PE20040080A1/es not_active Application Discontinuation
- 2003-04-02 AR ARP030101144A patent/AR039221A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003082285A1 (en) | 2003-10-09 |
| PE20040080A1 (es) | 2004-04-22 |
| EP1350512A1 (en) | 2003-10-08 |
| AU2003221532A1 (en) | 2003-10-13 |
| RU2004132205A (ru) | 2005-09-10 |
| BR0308982A (pt) | 2005-01-04 |
| JP2005522467A (ja) | 2005-07-28 |
| US20030228359A1 (en) | 2003-12-11 |
| MXPA04009582A (es) | 2005-01-11 |
| EP1492532A1 (en) | 2005-01-05 |
| PL371382A1 (en) | 2005-06-13 |
| CA2477751A1 (en) | 2003-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR039221A1 (es) | Combinaciones de epinastina, belladona y pseudoefedrina como formulaciones farmaceuticas | |
| UY26977A1 (es) | Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgésicos | |
| ECSP088404A (es) | Nuevos derivados de imidazo[4,5-b]piridina como inhibidores de la glucógeno sintasa quinasa 3, para uso en el tratamiento de demencia y trastornos neurodegenerativos | |
| CR8102A (es) | Derivados de pirazolo- quinazolina, procedimiento para preparacion y su uso como inhibidores de quinasa | |
| ES2076935T3 (es) | Compuesto de pirazolopiridina y procedimientos para su preparacion. | |
| AR030190A1 (es) | Una pirimidinona o una sal farmaceuticamente aceptable de la misma, composicion farmaceutica que la comprende, uso de dicho compuesto en la fabricacion de medicamentos y procedimiento para prepararlo | |
| BRPI0413393A (pt) | fexofenadina, composição farmaceuticamente aceitável, método de tratamento antihistamìnico, composição, processo para preparar fexofenadina e uso de fexofenadina | |
| US6489329B2 (en) | Pharmaceutical compositions for the treatment of rhinitis | |
| AR029766A1 (es) | Compuesto inhibidor de quinasa y uso del mismo para preparar una composicion farmaceutica | |
| AR068947A1 (es) | Inhibidor de la proteina activadora de la 5- lipoxigenasa (flap), composiciones farmaceuticas, sales y solvatos | |
| HN2004000232A (es) | " derivados de pirrolo(3,4-c) pirazol activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que los comprenden." | |
| AR034396A1 (es) | Compuestos 4-(1r-4-piperidilen)-4h-benzo[4,5]ciclohepta[1,2]-tiofeno-1-a y sus isomeros opticamente activos, un metodo para su sintesis y el uso de dichos compuestos para la manufactura de un medicamento | |
| AR040248A1 (es) | Farmaco para el tratamiento de la vejiga hiperactiva | |
| AR087240A2 (es) | Composiciones farmaceuticas que tienen epinastina y pseudoefedrina | |
| CL2024003616A1 (es) | Composición farmacéutica oral y uso para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| AR018505A1 (es) | COMPOSICIoN FARMACÉUTICA ANTIHISTAMíNICA CON UN INHIBIDOR DE LA P-GLICOPROTEíNA Y EL USO DE DICHA COMPOSICIoN PARA LA FABRICACIoN DE MEDICAMENTOS PARA AUMENTAR LA BIODISPONIBILIDAD DE DICHO ANTIHISTAMíNICO. | |
| SE0102440D0 (sv) | New compound | |
| UY28979A1 (es) | Derivados de hidrocloruros de 3-carboxamida, composiciones farmacéuticas que los contienen, procedimiento de preparación y su uso, útiles como inhibidores selectivos de gsk3 | |
| RU2000106042A (ru) | Способ повышения биологической доступности фексофенадина и его производных | |
| ES2115571T3 (es) | Uso de polisulfato de pentosana para la resolucion de cicatrices en enfermedades vasculares progresivas cronicas. | |
| AR052062A1 (es) | Composicion y metodo para tratar el asma | |
| AR037496A1 (es) | Uso novedoso del 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano y sus sales fisiologicamente aceptables | |
| AR040764A1 (es) | Formulaciones farmaceuticas de epinastina, pseudoefedrina y metilefedrina | |
| UY27747A1 (es) | Combinaciones de epinastina, belladona y pseudoefedrina como nuevas formulaciones farmacéuticas. | |
| UY27001A1 (es) | Derivados de la indolilpiperidina como agentes antihistamínicos y antialérgicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |